FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092862 [Registered on: 12/08/2025] Trial Registered Prospectively
Last Modified On: 11/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Other 
Public Title of Study   A Comparative Clinical Trial To Assess The Effect Of Piccha Basti And Balaguduchyadi Taila Matra Basti In The Managment Of Abnormal Uterine Bleeding 
Scientific Title of Study   A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PICCHA BASTI WITH BALAGUDUCCHYADI TAILA MATRA BASTI IN THE MANAGEMENT OF ASRIGDAR W.S.R. ABNORMAL UTERINE BLEEDING. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Priya 
Designation  MS Scholar Stree Roga Prasuti Tantra  
Affiliation  Institute For Ayurved Studies And Research 
Address  OPD NO 15 Department Of Stree Roga Prasuti Tantra Institute For Ayurved Studies And Research Umri Road Sector 8 Kurukshetra Haryana

Kurukshetra
HARYANA
136118
India 
Phone  8882130575  
Fax    
Email  priyapanchal8335@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitesh Kumar Panda  
Designation  Chairperson 
Affiliation  Institute For Ayurved Studies And Research 
Address  Room No 112 PG Department Of Stree Roga Prasuti Tantra Institute For Ayurved Studies And Research Umri Road Sector 8 Kurukshetra Haryana

Kurukshetra
HARYANA
136118
India 
Phone  9896033056  
Fax    
Email  drjk67@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Priya 
Designation  MS Scholar Stree Roga Prasuti Tantra  
Affiliation  Institute For Ayurved Studies And Research  
Address  OPD NO 15 Department Of Stree Roga Prasuti Tantra Institute For Ayurved Studies And Research Umri Road Sector 8 Kurukshetra Haryana

Kurukshetra
HARYANA
136118
India 
Phone  8882130575  
Fax    
Email  priyapanchal8335@gmail.com  
 
Source of Monetary or Material Support  
Institute For Ayurved Studies And Research Sector 8 Umri Road Kurukshetra PIN 136118 Haryana India 
 
Primary Sponsor  
Name  Institute For Ayurved Studies And Research  
Address  Sector 8 Umri Road Kurukshetra PIN 136118 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priya  Institute For Ayurved Studies And Research  OPD NO 15 Department Of Stree Roga Prasuti Tantra Institute For Ayurved Studies And Research Umri Road Sector 8 Kurukshetra Haryana
Kurukshetra
HARYANA 
8882130575

priyapanchal8335@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC SKAU KURUKSHETRA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N719||Inflammatory disease of uterus, unspecified. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: CHARAK SAMHITA, Procedure details: 20 Patients Will Be Treated With Piccha Basti After Cessation Of Menses For 8 Days For 3 Consecutive Cycles Dosage 300 ML)
(1) Medicine Name: Piccha Basti, Reference: Charak Chikitsa Chapter 14 Shloka 225 To 228, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 300(ml), Frequency: od, Duration: 8 Days
2Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Charak Samhita, Procedure details: 20 Patients Will Be Treated With Balaguduchyadi Taila Matra Basti After The Cessation Of Menses For 8 Days For 3 Consecutive Cycles)
(1) Medicine Name: Balaguduchyadi Taila , Reference: Charak Siddhi Sthan Chapter 3 Shloka 16 To 19, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 8 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Excessive Menstrual Bleeding
Intermenstrual Bleeding
Prolonged Bleeding
Patients Willing To Participate And Provide Informed Consent In Trial 
 
ExclusionCriteria 
Details  Uterine And Pelvic Pathology
Use Of IUCD
Bleeding Caused By Miscarriage
Inevitable Abortion
Cardiovascular Renal Coagulation Chronic Systemic Disease
Bleeding Site Other Than Uterus
Develop Condition Which May Require Other Treatment 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Improve The Grading Of Menorrhagia And Duration Of Bleeding  Follow Up Will Be Done On 60 90 120 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement In The Haemoglobin Level
Improvement In The Endometrial Thickness 
Follow Up Will Be Done On 60 90 120 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   ABNORMAL UTERINE BLEEDING DEFINED AS ANY DEVIATION FROM THE NORMAL MENSTRUAL CYCLE IN TERMS OF FREQUENCY DURATION REGULARITY OR VOLUME OF BLOOD FLOW THAT IS NOT RELATED TO PREGNANCY. IT AFFECTS WOMENS PHYSICAL,SOCIAL,EMOTIONAL WELL BEING.WHILE CONVENTIONAL TREATMENTS OFFERS  SYMPTOMATIC RELIEF THEY ARE ASSOCIATED WITH SIDE EFFECTS AND MAY NOT BE SUITABLE FOR ALL PATIENTS.THIS RANDOMIZATION OPEN LABEL COMPARATIVE CLINICAL STUDY IS TO EVALUATE THE EFFICACY OF PICCHA BASTI WITH BALAGUDUCHYADI TAILA MATRA BASTI .THE STUDY INVOLVES 40 PARTICIPANTS WHO ARE DIAGNOSED WITH AUB BASED ON CLINICAL EVALUATION AND SUPPORTING INVESTIGATIONS.PICCHA BASTI KNOWN FOR ITS ASTRINGENT PROPERTY AND BALAGUCHYADI TAILA FOR A NUTRITIVE AND VATA PACIFYING AYURVEDIC FORMULATION FOR MANAGING ASRIGDAR.THIS WILL BE ADMINISTERED FOR 3 MONTHS AIMING TO REDUCE SYMPTOMS SUCH AS EXCESSIVE MENSTRUAL BLEEDING,INTERMENSTRUAL BLEEDING,AND OTHER SYMPTOMS.OUTCOME MEASURE WILL INCLUDE BOTH SUBJECTIVE AND OBJECTIVE PARAMETERS .THIS STUDY WILL OFFER A POTENTIALLY SAFER ALTERNATIVE TO CONVENTIONAL TREATMENT. 
Close